Swan Global Investments LLC acquired a new stake in shares of Cibus, Inc. (NASDAQ:CBUS – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 35,123 shares of the company’s stock, valued at approximately $115,000. Swan Global Investments LLC owned 0.13% of Cibus at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in CBUS. FMR LLC lifted its position in Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after buying an additional 566,328 shares during the period. Armistice Capital LLC purchased a new position in shares of Cibus in the 2nd quarter worth about $5,083,000. Bank of New York Mellon Corp purchased a new position in shares of Cibus in the 2nd quarter worth about $529,000. Vanguard Group Inc. raised its position in shares of Cibus by 3.7% in the 1st quarter. Vanguard Group Inc. now owns 721,945 shares of the company’s stock worth $16,215,000 after purchasing an additional 26,017 shares during the last quarter. Finally, Rhumbline Advisers purchased a new position in shares of Cibus in the 2nd quarter worth about $221,000. Hedge funds and other institutional investors own 33.81% of the company’s stock.
Wall Street Analyst Weigh In
CBUS has been the subject of several recent analyst reports. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $20.00 price target on shares of Cibus in a research report on Tuesday, October 22nd. Alliance Global Partners decreased their target price on Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a research report on Tuesday, September 24th. Finally, HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Cibus in a research report on Monday, November 11th.
Cibus Trading Up 2.2 %
Shares of Cibus stock traded up $0.10 during trading hours on Wednesday, reaching $4.59. 4,975 shares of the stock traded hands, compared to its average volume of 135,677. The company has a 50 day moving average price of $3.93 and a 200 day moving average price of $7.70. Cibus, Inc. has a one year low of $2.86 and a one year high of $23.18.
Cibus Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Articles
- Five stocks we like better than Cibus
- How to Invest in Small Cap StocksĀ
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Start Investing in Real Estate
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Where Do I Find 52-Week Highs and Lows?
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding CBUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cibus, Inc. (NASDAQ:CBUS – Free Report).
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.